Volume 101, Issue 3 pp. 553-562
ORIGINAL ARTICLE - CLINICAL SCIENCE

Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial

Sandeep Arunothayaraj MBBS

Corresponding Author

Sandeep Arunothayaraj MBBS

Department of Cardiology, Sussex Cardiac Centre, University Hospitals Sussex NHS Trust, Brighton, UK

Correspondence Sandeep Arunothayaraj, MBBS, Department of Cardiology, Sussex Cardiac Centre, University Hospitals Sussex NHS Trust, Eastern Rd, Brighton BN2 5BE, UK.

Email: [email protected] and [email protected]

Search for more papers by this author
Jens Flensted Lassen PhD

Jens Flensted Lassen PhD

Department of Cardiology, Odense University Hospital, Odense, Denmark

Search for more papers by this author
Gerald J. Clesham PhD

Gerald J. Clesham PhD

Department of Cardiology, Essex Cardiothoracic Centre, Basildon, Essex, UK

Cardiovascular System Block, MTRC, Anglia Ruskin School of Medicine, Chelmsford, Essex, UK

Search for more papers by this author
Mark S. Spence MD

Mark S. Spence MD

Department of Cardiology, Belfast Health and Social Care Trust, Belfast, UK

Search for more papers by this author
René Koning MD

René Koning MD

Department of Cardiology, Clinique Saint Hilaire, Rouen, France

Search for more papers by this author
Adrian P. Banning MD

Adrian P. Banning MD

Department of Cardiology, Oxford Heart Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Search for more papers by this author
Mitchell Lindsay MD

Mitchell Lindsay MD

Department of Cardiology, West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK

Search for more papers by this author
Evald H. Christiansen PhD

Evald H. Christiansen PhD

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark

Search for more papers by this author
Mohaned Egred MD

Mohaned Egred MD

Department of Cardiology, Freeman Hospital & Newcastle University, Newcastle upon Tyne, UK

Search for more papers by this author
James Cockburn MD

James Cockburn MD

Department of Cardiology, Sussex Cardiac Centre, University Hospitals Sussex NHS Trust, Brighton, UK

Search for more papers by this author
Darren Mylotte PhD

Darren Mylotte PhD

Department of Cardiology, University Hospital and National University of Ireland, Galway, Ireland

Search for more papers by this author
Philippe Brunel MD

Philippe Brunel MD

Interventional Cardiology Unit, Clinique de Fontaine, Dijon, France

Search for more papers by this author
Miroslaw Ferenc PhD

Miroslaw Ferenc PhD

Division of Cardiology and Angiology II, Universitäts-Herzzentrum Bad Krozingem, Bad Krozingen, Germany

Search for more papers by this author
Thomas Hovasse MD

Thomas Hovasse MD

Department of Cardiology, Institut Cardiovasculaire Paris Sud, Ramsay Santé, Massy, France

Search for more papers by this author
Adrian Wlodarczak PhD

Adrian Wlodarczak PhD

Department of Cardiology, Poland Miedziowe Centrum Zdrowia Lubin, Lubin, Poland

Search for more papers by this author
Manuel Pan PhD

Manuel Pan PhD

Department of Cardiology, Reina Sofia Hospital, University of Cordoba (IMIBIC), Cordoba, Spain

Search for more papers by this author
Marc Silvestri MD

Marc Silvestri MD

Department of Cardiology, GCS Axium, Rambot, Aix en Provence, France

Search for more papers by this author
Andrejs Erglis PhD

Andrejs Erglis PhD

Department of Cardiology, Pauls Stradins Clinical University Hospital, University of Latvia, Riga, Latvia

Search for more papers by this author
Evgeny Kretov MD

Evgeny Kretov MD

Interventional Cardiology Unit, Sibirskiy Fеdеrаl Biomedical Research Center Novosibirsk, Novosibirsk, Russia

Search for more papers by this author
Alaide Chieffo MD

Alaide Chieffo MD

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy

Search for more papers by this author
Thierry Lefèvre MD

Thierry Lefèvre MD

Department of Cardiology, Institut Cardiovasculaire Paris Sud, Ramsay Santé, Massy, France

Search for more papers by this author
Francesco Burzotta PhD

Francesco Burzotta PhD

Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Search for more papers by this author
Olivier Darremont MD

Olivier Darremont MD

Department of Cardiology, Clinique Saint-Augustin-Elsan, Bordeaux, France

Search for more papers by this author
Goran Stankovic PhD

Goran Stankovic PhD

Department of Cardiology, University Clinical Center of Serbia and Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Search for more papers by this author
Marie-Claude Morice MD

Marie-Claude Morice MD

Department of Cardiology, Institut Cardiovasculaire Paris Sud, Ramsay Santé, Massy, France

Search for more papers by this author
Yves Louvard MD

Yves Louvard MD

Department of Cardiology, Institut Cardiovasculaire Paris Sud, Ramsay Santé, Massy, France

Search for more papers by this author
David Hildick-Smith MD

David Hildick-Smith MD

Department of Cardiology, Sussex Cardiac Centre, University Hospitals Sussex NHS Trust, Brighton, UK

Search for more papers by this author
First published: 29 January 2023
Citations: 2

Abstract

Background

Techniques for provisional and dual-stent left main bifurcation stenting require optimization.

Aim

To identify technical variables influencing procedural outcomes and periprocedural myocardial infarction following left main bifurcation intervention.

Methods

Procedural and outcome data were analyzed in 438 patients from the per-protocol cohort of the European Bifurcation Club Left Main Trial (EBC MAIN). These patients were randomized to the provisional strategy or a compatible dual-stent extension (T, T-and-protrude, or culotte).

Results

Mean age was 71 years and 37.4% presented with an acute coronary syndrome. Transient reduction of side vessel thrombolysis in myocardial infarction flow occurred after initial stent placement in 5% of procedures but was not associated with periprocedural myocardial infarction. Failure to rewire a jailed vessel during any strategy was more common when jailed wires were not used (9.5% vs. 2.5%, odds ratio [OR]: 6.4, p = 0.002). In the provisional cohort, the use of the proximal optimization technique was associated with less subsequent side vessel intervention (23.3% vs. 41.9%, OR: 0.4, p = 0.048). Side vessel stenting was predominantly required for dissection, which occurred more often following side vessel preparation (15.3% vs. 4.4%, OR: 3.1, p = 0.040). Exclusive use of noncompliant balloons for kissing balloon inflation was associated with reduced need for side vessel intervention in provisional cases (20.5% vs. 38.5%, OR: 0.4, p = 0.013), and a reduced risk of periprocedural myocardial infarction across all strategies (2.9% vs. 7.7%, OR: 0.2, p = 0.020).

Conclusion

When performing provisional or compatible dual-stent left main bifurcation intervention, jailed wire use is associated with successful jailed vessel rewiring. Side vessel preparation in provisional patients is linked to increased side vessel dissection requiring stenting. Use of the proximal optimization technique may reduce the need for additional side vessel intervention, and noncompliant balloon use for kissing balloon inflation is associated with a reduction in both side vessel stenting and periprocedural myocardial infarction.

Clinical Trial Registration

ClinicalTrials.gov Identifier NCT02497014.

CONFLICTS OF INTEREST STATEMENT

D. H.-S. is a proctor/advisory to Boston, Abbott, Medtronic, Terumo, Edwards, Occlutech, Gore; CERC. A. C. is a Consultant at Abiomed, Biosensor, Magenta and received Speakers fees from Abbott vascular, Abiomed, Boston Scientific, Cardinal Health. T. L. lectures Abbott Proctoring, Edwards Proctoring, Lectures, Boston scientific, Terumo Proctoring. M.-C. M. is a Shareholder and CEO of CERC. M. P. received Lecture fees Abbott, Boston. J. F. L. received Lecturing and Honoraria for Medtronic, Boston Scientific, Biotronik, Biosensors. A. B. received lecture fees Boston. O. D. received lecture fees for Boston and Edwards. F. B. received lecture fees from Abiomed, Abbott, Medtronic, Terumo. M. E. received honoraria, proctorship and speaker's fee for Abbott Vascular, Boston Scientific, Philips, Spectranetics, Volcano, Vascular Perspective, Merrill, Sveltte, EPS Medical, Astra Zeneca. G. S. received speaker fees from Medtronic, Abbott Vascular, and Terumo. M. S. received honoraria for Medtronic, Edwards Lifesciences, Abbott, Boston Scientific, and Gore. D. M. is a consultant for Medtronic, Boston Scientific, and Microport. The remaining authors declare no conflicts of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.